Lead storyLead story · #earnings
Gilead raises sales outlook; shares climb 3% after HIV-led quarter
Gilead’s HIV growth lifts its sales outlook, but acquisition charges deepen its annual loss forecast. What Friday’s rally means for option sellers.
Topic desk · #hiv
1 story filed under #hiv, newest first.
Stories on this topic
1
Tagged #hiv
Photo: Coolcaesar / Wikimedia Commons, CC BY 4.0; archival July 4, 2023, cropped and resized.
Last 24 h
6
Recaps and market notes
This week
43
Stories filed in 7 days
Pro Tips
43
Trade ideas in 7 days
Research
25
Tickers under coverage
01
1 article tagged #hiv
Lead storyLead story · #earnings
Gilead’s HIV growth lifts its sales outlook, but acquisition charges deepen its annual loss forecast. What Friday’s rally means for option sellers.
02
The rest of the newsroom: wheel lessons, how-to guides and the freshest research.
Pro Tips
All Pro Tips03
One email each Sunday, free. Unsubscribe anytime.
The Wheelhouse · free
The weekly brief for wheel sellers
Every Sunday, the week ahead for option sellers in one short email.
Educational only — not financial advice.
Keep YieldCove close
Choose YieldCove as a preferred source for Top Stories in Google Search.
Free forever
The wheel tracker is free: every put, call and assignment in one running P/L, with Invest, Budget and a Trading journal beside it.